J&J Kept Quiet on Popular Diabetes Drug as Red Flags Multiplied
Gathered for an emergency meeting, the Johnson & Johnson drug safety team painted an alarming scene: people taking the company's new blockbuster diabetes drug were falling gravely ill.
Source: medscape.com